Cell and gene therapies promise one-dose cures and drive South Korea biotech growth South Korea positions itself as a hub for ...
Chennai: To prepare students to answer application-oriented questions from a young age, state school education department ...
The Society for Immunotherapy of Cancer (SITC) received an incredible number of abstract submissions in 2025, more than 1,300, including many clinical based Late-breaking Abstracts. SITC is proud to ...
Net Loss -- Net loss was $13.6 million for the third quarter of 2025, compared to $16.4 million in Q3 2024. Ending Cash, Cash ...
With its inherent strengths, New York State is achieving gains in both domestic and international markets. | ...
Good morning, and welcome to the SELLAS Life Sciences R&D Day. As a reminder, this call is being recorded, and a replay will be made available on the SELLAS website following the conclusion of the ...
Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
A new computational framework developed by a team with Professor Chris Wolverton maps atomic ordering to unlock ...
Q3 2025 Earnings Call Transcript October 28, 2025 Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS ...
Baron Health Care Fund gained for the quarter and outperformed its benchmark, the Russell 3000 Health Care Index. Read more ...
Cystic fibrosis (CF) therapeutics refer to treatments designed to manage and alleviate the symptoms of cystic fibrosis, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback